Orimelan (Melatonin)

Melatonin works by binding to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus, the central clock that controls circadian rhythms. Activation of these receptors adjusts the timing of the internal clock, promoting sleep onset and helping the body align with the desired sleep schedule.

The appropriate dose of Orimelan is determined by a qualified prescriber based on the patient’s age, condition, and response to therapy. Dosage may vary widely, ranging from low microgram amounts for children to higher doses for adults, and should always follow the healthcare professional’s recommendation.

Safety data for melatonin use in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting Orimelan.

To order Orimelan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Orimelan (melatonin) differs from conventional sedative sleep aids such as benzodiazepines or antihistamines because it works by resetting the circadian clock rather than inducing sedation. This mechanism typically results in fewer next‑day drowsiness effects, but efficacy may be limited to sleep disturbances linked to rhythm disorders. Individual response varies, so a healthcare professional should assess the most appropriate therapy.

Orimelan should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and heat sources. Ensure the container is tightly closed after each use to maintain product stability.

Orimelan is taken orally, usually with a glass of water. It can be taken with or without food, although some patients prefer taking it 30‑60 minutes before bedtime to align with the natural rise in endogenous melatonin levels.

Serious risks, though rare, include allergic reactions such as rash, swelling, or difficulty breathing, and hormonal effects that may alter menstrual cycles or cause mood disturbances. Patients should seek immediate medical attention if they experience signs of an allergic response or unexpected psychiatric symptoms.

Orimelan should be avoided by individuals with known hypersensitivity to melatonin or any excipients in the formulation. It is also contraindicated in patients taking certain medications that may interact severely, such as anticoagulants or immunosuppressants, without close medical supervision.